Jump Financial, LLC Red Hill Biopharma Ltd. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.65 - $3.12 $52,531 - $99,331	-31,837 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.31 - $5.85 $73,543 - $186,246	31,837 New	31,837 $82,000
Q3 2021 Nov 12, 2021	SELL	$4.55 - $10.36 $66,885 - $152,292	-14,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.98 - $7.51 $87,906 - $110,397	14,700 New	14,700 $101,000
Q1 2021 May 17, 2021	SELL	$6.98 - $11.29 $72,592 - $117,415	-10,400 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$7.81 - $10.39 $81,224 - $108,056	10,400 New	10,400 $84,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $176M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.